Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 2
1988 3
1989 2
1993 1
1994 1
1999 2
2000 3
2001 4
2002 4
2003 9
2004 13
2005 14
2006 18
2007 11
2008 11
2009 13
2010 11
2011 15
2012 11
2013 12
2014 12
2015 15
2016 18
2017 16
2018 13
2019 11
2020 10
2021 20
2022 8
2023 8
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

265 results

Results by year

Filters applied: . Clear all
Page 1
Terbium-161 for PSMA-targeted radionuclide therapy of prostate cancer.
Müller C, Umbricht CA, Gracheva N, Tschan VJ, Pellegrini G, Bernhardt P, Zeevaart JR, Köster U, Schibli R, van der Meulen NP. Müller C, et al. Among authors: bernhardt p. Eur J Nucl Med Mol Imaging. 2019 Aug;46(9):1919-1930. doi: 10.1007/s00259-019-04345-0. Epub 2019 May 27. Eur J Nucl Med Mol Imaging. 2019. PMID: 31134301 Free PMC article.
Everolimus with Reduced Calcineurin Inhibitor Exposure in Renal Transplantation.
Pascual J, Berger SP, Witzke O, Tedesco H, Mulgaonkar S, Qazi Y, Chadban S, Oppenheimer F, Sommerer C, Oberbauer R, Watarai Y, Legendre C, Citterio F, Henry M, Srinivas TR, Luo WL, Marti A, Bernhardt P, Vincenti F; TRANSFORM Investigators. Pascual J, et al. Among authors: bernhardt p. J Am Soc Nephrol. 2018 Jul;29(7):1979-1991. doi: 10.1681/ASN.2018010009. Epub 2018 May 11. J Am Soc Nephrol. 2018. PMID: 29752413 Free PMC article. Clinical Trial.
Two-year outcomes in de novo renal transplant recipients receiving everolimus-facilitated calcineurin inhibitor reduction regimen from the TRANSFORM study.
Berger SP, Sommerer C, Witzke O, Tedesco H, Chadban S, Mulgaonkar S, Qazi Y, de Fijter JW, Oppenheimer F, Cruzado JM, Watarai Y, Massari P, Legendre C, Citterio F, Henry M, Srinivas TR, Vincenti F, Gutierrez MPH, Marti AM, Bernhardt P, Pascual J; TRANSFORM investigators. Berger SP, et al. Among authors: bernhardt p. Am J Transplant. 2019 Nov;19(11):3018-3034. doi: 10.1111/ajt.15480. Epub 2019 Jul 1. Am J Transplant. 2019. PMID: 31152476 Free article. Clinical Trial.
Results from an EANM survey on time estimates and personnel responsible for main tasks in molecular radiotherapy dosimetry.
Gabiña PM, Gleisner KS, Cremonesi M, Stokke C, Flux G, Cicone F, Konijnenberg M, Aldridge M, Sandstrom M, Chiesa C, Paphiti M, Hippeläinen E, Uribe C, Solny P, Gnesin S, Bernhardt P, Chouin N, Costa PF, Glatting G, Verburg F, Gear J. Gabiña PM, et al. Among authors: bernhardt p. Eur J Nucl Med Mol Imaging. 2023 Jul;50(9):2595-2604. doi: 10.1007/s00259-023-06215-2. Eur J Nucl Med Mol Imaging. 2023. PMID: 37129712 No abstract available.
[Facelift and good form].
Bernhardt P. Bernhardt P. Tidsskr Nor Laegeforen. 2024 Jan 22;144(1). doi: 10.4045/tidsskr.24.01.01. Print 2024 Jan 23. Tidsskr Nor Laegeforen. 2024. PMID: 38258708 Free article. Norwegian. No abstract available.
Prognostic value of microvascular obstruction and infarct size, as measured by CMR in STEMI patients.
van Kranenburg M, Magro M, Thiele H, de Waha S, Eitel I, Cochet A, Cottin Y, Atar D, Buser P, Wu E, Lee D, Bodi V, Klug G, Metzler B, Delewi R, Bernhardt P, Rottbauer W, Boersma E, Zijlstra F, van Geuns RJ. van Kranenburg M, et al. Among authors: bernhardt p. JACC Cardiovasc Imaging. 2014 Sep;7(9):930-9. doi: 10.1016/j.jcmg.2014.05.010. JACC Cardiovasc Imaging. 2014. PMID: 25212799 Free article. Review.
265 results